pR26 GFP Dest Citations (3)

Originally described in: Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kuhn R BMC Biotechnol. 2016 Jan 16;16(1):4. doi: 10.1186/s12896-016-0234-4. PubMed Journal

Articles Citing pR26 GFP Dest

Showing 1 to 3 of 3 entries

Show entries

Search table:

Articles
Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy. Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles JB, Deitch BJ, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz HB, Grubisha MJ, Huang YH, Thomas G. Nat Commun. 2023 Oct 17;14(1):6547. doi: 10.1038/s41467-023-42176-8. PubMed
RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice. Thomas G, Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles J, Deitch B, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz H, Grubisha M, Huang Y. Res Sq. 2023 Jan 27:rs.3.rs-2440581. doi: 10.21203/rs.3.rs-2440581/v1. Preprint. PubMed
Pituitary Tumors and Immortalized Cell Lines Generated by Cre-Inducible Expression of SV40 T Antigen. Daly AZ, Mortensen AH, Bando H, Camper SA. Endocrinology. 2021 Jul 1;162(7). pii: 6219492. doi: 10.1210/endocr/bqab073. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.